Status:

COMPLETED

PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

Lead Sponsor:

Korea University Anam Hospital

Collaborating Sponsors:

GL Pharm Tech Corporation

Conditions:

Benign Prostatic Hyperplasia (BPH)

Eligibility:

MALE

20-45 years

Phase:

PHASE1

Brief Summary

To compare the relative bioavailability and pharmacokinetic characteristics of a newly single pill combination of finasteride and tamsulosin with a conventional combination of finasteride and tamsulos...

Detailed Description

This single dose, open label, balanced, randomized, two-treatment, two-period, two-sequence, crossover study was conducted to compare the relative bioavailability and pharmacokinetic characteristics o...

Eligibility Criteria

Inclusion

  • Males age 20 to 45 years
  • Body weight \> 50 kg with 18\~29 kg/m2 body mass index (BMI)
  • Signed and dated informed consent form which meets all criteria of current FDA and KFDA regulations

Exclusion

  • subjects with acute conditions.
  • presence of history affecting ADME
  • Clinically significant history or current evidence of a hepatic, renal, gastrointestinal, or hematologic abnormality
  • Hepatitis B, hepatitis C, or HIV infection revealed on the laboratory findings
  • Any other acute or chronic disease
  • A history of hypersensitivity to donepezil
  • A history of alcohol or drug abuse
  • Participation in another clinical trial within 3 months
  • smoked \>10 cigarettes daily
  • consumption over 5 glasses daily of beverages containing xanthine derivatives
  • use of any medication having the potential to affect the study results within 10 days before the start of the study.
  • AST or ALT \> 1.25 of upper normal limit
  • total bilirubin \> 1.5 of upper normal limit
  • systolic blood pressure \< 90 mmHg
  • calculated CLcr using Cockroft-Gault equation \< 50 mL/min

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2012

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT01829893

Start Date

January 1 2012

End Date

February 1 2012

Last Update

April 11 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical trial center of Anam Hospital

Seoul, South Korea, 136-705